Further incidences of insertional mutagenesis related cancer have been identified in patients treated for cerebral adrenoleukodystrophy...

TestAVec's chairman, Mr Robert Spencer, and Chief Scientific Officer, Prof. Micahel Themis, will be attending this year's congress of the...

In March 2023, the NC3Rs and UKEMS hosted a groundbreaking meeting, originally conceived by TestAVec and Novartis, of top experts in gene...

DAVID LASKOW-POOLEY JOINS BOARD OF TESTAVEC LTD David Laskow- Pooley has joined the company to accelerate the commercialisation of the...

TestAVec researchers, lead by CSO Professor Michael Themis, have devised new protocols for making high titre HIV-1 lentivirus particles...